ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis
USA - NASDAQ:ESTA - VGG312491084 - Common Stock
63.19 USD
-5.26 (-7.68%)
63.19 USD
0 (0%)
ESTA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. ESTA has a bad profitability rating. Also its financial health evaluation is rather negative. ESTA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ESTA has reported negative net income.
In the past year ESTA has reported a negative cash flow from operations.
In the past 5 years ESTA always reported negative net income.
ESTA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ESTA has a Return On Assets of -27.27%. This is comparable to the rest of the industry: ESTA outperforms 46.56% of its industry peers.
With a Return On Equity value of -391.30%, ESTA is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.27% | ||
| ROE | -391.3% | ||
| ROIC | N/A |
ROA(3y)-29.83%
ROA(5y)-28.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ESTA (67.24%) is better than 72.49% of its industry peers.
ESTA's Gross Margin has been stable in the last couple of years.
ESTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
2. Health
2.1 Basic Checks
ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ESTA has more shares outstanding
The number of shares outstanding for ESTA has been increased compared to 5 years ago.
ESTA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.28 indicates that ESTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
ESTA has a Altman-Z score of 2.28. This is in the better half of the industry: ESTA outperforms 65.08% of its industry peers.
ESTA has a Debt/Equity ratio of 9.61. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 9.61, ESTA is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.28 |
ROIC/WACCN/A
WACC8.27%
2.3 Liquidity
A Current Ratio of 2.83 indicates that ESTA has no problem at all paying its short term obligations.
ESTA has a Current ratio (2.83) which is comparable to the rest of the industry.
ESTA has a Quick Ratio of 1.65. This is a normal value and indicates that ESTA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ESTA (1.65) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.83 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
The earnings per share for ESTA have decreased strongly by -10.08% in the last year.
The Revenue has been growing slightly by 0.53% in the past year.
The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
3.2 Future
ESTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.95% yearly.
ESTA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.06% yearly.
EPS Next Y28.5%
EPS Next 2Y27.69%
EPS Next 3Y25.3%
EPS Next 5Y25.95%
Revenue Next Year25.67%
Revenue Next 2Y24.79%
Revenue Next 3Y24.57%
Revenue Next 5Y26.06%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ESTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ESTA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ESTA's earnings are expected to grow with 25.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.69%
EPS Next 3Y25.3%
5. Dividend
5.1 Amount
ESTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
63.19
-5.26 (-7.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners104.53%
Inst Owner Change-3.95%
Ins Owners6.86%
Ins Owner Change-7.46%
Market Cap1.83B
Revenue(TTM)166.03M
Net Income(TTM)-90.00M
Analysts84
Price Target58.27 (-7.79%)
Short Float %18.49%
Short Ratio15.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-4.97%
Max EPS beat(2)14.35%
EPS beat(4)2
Avg EPS beat(4)-14.93%
Min EPS beat(4)-75.04%
Max EPS beat(4)14.35%
EPS beat(8)4
Avg EPS beat(8)-10.7%
EPS beat(12)7
Avg EPS beat(12)-5.04%
EPS beat(16)8
Avg EPS beat(16)-27.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)-1.31%
Revenue beat(4)0
Avg Revenue beat(4)-1.86%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)-1.31%
Revenue beat(8)2
Avg Revenue beat(8)-1.78%
Revenue beat(12)5
Avg Revenue beat(12)-1.11%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)0.66%
PT rev (3m)-1.27%
EPS NQ rev (1m)-2.19%
EPS NQ rev (3m)-10.65%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-3.97%
Revenue NQ rev (1m)-0.98%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 10.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 79.59 | ||
| P/tB | 169.66 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.84
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-2.8
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS6.12
BVpS0.79
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.27% | ||
| ROE | -391.3% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.24% | ||
| FCFM | N/A |
ROA(3y)-29.83%
ROA(5y)-28.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 91.73% | ||
| Cap/Sales | 4.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.83 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | 2.28 |
F-Score5
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)573.1%
Cap/Depr(5y)401.12%
Cap/Sales(3y)15.32%
Cap/Sales(5y)11.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
EPS Next Y28.5%
EPS Next 2Y27.69%
EPS Next 3Y25.3%
EPS Next 5Y25.95%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
Revenue Next Year25.67%
Revenue Next 2Y24.79%
Revenue Next 3Y24.57%
Revenue Next 5Y26.06%
EBIT growth 1Y-2.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.98%
EBIT Next 3Y40.51%
EBIT Next 5Y43.1%
FCF growth 1Y28.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.97%
OCF growth 3YN/A
OCF growth 5YN/A
ESTABLISHMENT LABS HOLDINGS / ESTA FAQ
What is the fundamental rating for ESTA stock?
ChartMill assigns a fundamental rating of 3 / 10 to ESTA.
Can you provide the valuation status for ESTABLISHMENT LABS HOLDINGS?
ChartMill assigns a valuation rating of 1 / 10 to ESTABLISHMENT LABS HOLDINGS (ESTA). This can be considered as Overvalued.
Can you provide the profitability details for ESTABLISHMENT LABS HOLDINGS?
ESTABLISHMENT LABS HOLDINGS (ESTA) has a profitability rating of 1 / 10.
Can you provide the financial health for ESTA stock?
The financial health rating of ESTABLISHMENT LABS HOLDINGS (ESTA) is 3 / 10.